Compare Inovio Pharmaceuticals Inc (INO) vs Kimberly Clark Corp (KMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs Kimberly Clark Corp — how do they compare? Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M), while Kimberly Clark Corp trades at $108.85 (market cap $36.01B). The key difference: Kimberly Clark Corp is far larger — about 403.4× Inovio Pharmaceuticals Inc's market cap, and Kimberly Clark Corp pays a 4.72% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | KMB | |
|---|---|---|
Market Cap | $89.27M | $36.01B |
Sector | Health | Consumer Staples |
52-Week High | $2.87 | $136.77 |
52-Week Low | $1.05 | $93.05 |
Enterprise Value | $60.28M | $42.55B |
Dividend Yield | — | 4.72% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About Kimberly Clark Corp
With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →
